AAD
  • Meeting Program
  • Registration
  • Daily Coverage
  • Photo Gallery
  • Samples & Solutions
Topics
  • Daily Coverage
  • Photo Gallery
  • Samples & Solutions
Resources
  • Meeting Program
  • Registration
Facebook iconInstagram iconTwitter X icon
Aug 12, 2023

What we’ve learned about psoriatic arthritis

Everett C. Fox Memorial Lectureship traces the path to improvement in patient care.


Alice B. Gottlieb, MD, PhD, FAAD
Alice B. Gottlieb, MD, PhD, FAAD

N001 – Named Lecture Presentations: Everett C. Fox MD Memorial Award and Lectureship: The Critical Role of the Dermatologist in the Treatment of Psoriatic Arthritis

Evaluating data from patient-reporting tools can significantly improve symptom management, disease progression, and quality of life for people diagnosed with psoriatic arthritis. That was the message from Everett C. Fox MD Memorial Award recipient Alice B. Gottlieb, MD, PhD, FAAD, during Friday’s “N001 – Named Lecture Presentations: Everett C. Fox MD Memorial Award and Lectureship: The Critical Role of the Dermatologist in the Treatment of Psoriatic Arthritis.” Dr. Gottlieb is clinical medical director at Mount Sinai Union Square in New York City and founder and president of the International Dermatology Outcome Measures (IDEOM) group.  

During her lecture, Dr. Gottlieb emphasized the role dermatologists play in screening for and treating cases of psoriatic arthritis. Using patient-reported tools during the screening phase is key to customizing plans that treat patient-reported targets.

“Effective screening by dermatologists allows for the early detection of PSA,” she said. “Early treatment of PSA and treating to target for PSA have been demonstrated to result in better clinical outcomes, a better quality of life, and less disability.”

Forging the path

For the last 30 years, AAD has selected a leading clinical dermatologist to receive an award and give a lecture in honor of Everett C. Fox, MD, who was a practicing clinician in Texas and was vice president of the American Academy of Dermatology in 1946.  Dr. Gottlieb’s work in this specialty has been far-reaching and groundbreaking. Several firsts that she’s accomplished include:

  • Demonstrating that psoriasis was not merely a keratinization disorder, but also an immune-mediated disease
  • Proving that TNF blockers when used as a monotherapy can clear psoriasis
  • Establishing dermatology as a field for biologics development

In short, Dr. Gottlieb has been a forerunner in shifting how clinicians understand, identify, classify, and study psoriasis as well as improving the treatment options for patients who have psoriasis. She has also completed considerable research in psoriatic arthritis (PSA) — as reflected in her presentation — vitiligo, hidradenitis suppurativa, cutaneous lupus, and other immune-mediated disorders.

Fortifying the future

Dr. Gottlieb concluded her lecture with several bold and promising projections for the field. She believes that dermatologists will be able to predict which psoriasis patients will develop psoriatic arthritis and, of those, which ones will likely experience joint damage. She also wants dermatologists to learn how to use ultrasound as a method to identify early signs of enthesitis, which is often the earliest sign of psoriatic arthritis.

“Dermatologists are in the best position to make a diagnosis of early psoriatic arthritis given that 84% of patients have psoriasis 10-12 years before they develop PSA,” said Dr. Gottlieb. “Additionally, there are data to show that treatment of psoriasis with biologics before patients have any evidence of PSA results in a lower incidence of future PSA compared to control treatments not using biologics.”

Looking forward, Dr. Gottlieb said she will monitor advancements in gene therapy and how it will affect genodermatoses management as well as how artificial intelligence will play a role in the practice of dermatology. She is also hopeful that the expansion of biosimilar drug use will increase access and decrease the cost of biologics and other more expensive drugs.

Dr. Gottlieb expressed her gratitude to AAD, its leadership, and its membership for the renowned recognition. As a board-certified physician in not only dermatology but also rheumatology and internal medicine, Dr. Gottlieb has authored approximately 500 peer-reviewed articles and has presented her research at more than 350 medical conferences around the world.

“I am grateful to my wonderful husband for his encouragement,” she said. “As a first-generation American and daughter of a widowed Holocaust survivor, I am also grateful for my family’s support and am proud of my accomplishments. I wish my mother Eva Schenk, of blessed memory, could see this special day, but I am thinking of her.”

Interesting Stories
DermWorld  January | Scar solutions
Presented by AAD
DermWorld January | Scar solutions
DermWorld March | Publishing profiteers
Presented by AAD
DermWorld March | Publishing profiteers
DermWorld December | Disease reporting
Presented by AAD
DermWorld December | Disease reporting
DermWorld February | Glow Up
Presented by AAD
DermWorld February | Glow Up
DermWorld April | Shedding light on treatments for female pattern hair loss
Presented by AAD
DermWorld April | Shedding light on treatments for female pattern hair loss
DermWorld November | Scent-itive skin
Presented by AAD
DermWorld November | Scent-itive skin
More in Innovation Academy 2023
2 J6 A5263
Innovation Academy 2023
Successful 2023 Innovation Academy closes the gap on learning
Aug 18, 2023
2022 03 21 12 26 25 6238b55bf2d38 640e3f2761020
Innovation Academy 2023
2023 Innovation Academy: Claim CME
Aug 18, 2023
Kenneth J. Tomecki, MD, FAAD
Innovation Academy 2023
Science backs vitamin treatment for pediatric eczema
Aug 18, 2023
Keyvan Nouri, MD, MBA, FAAD
Innovation Academy 2023
Business as usual?
Aug 18, 2023
M. Laurin Council, MD, MBA, FAAD
Innovation Academy 2023
On the rare side of skin cancer
Aug 18, 2023
Carolyn Goh, MD, FAAD
Innovation Academy 2023
More than a head of hair
Aug 18, 2023
Gil Yosipovitch, MD, FAAD
Innovation Academy 2023
Don’t ignore the power and persistence of itch
Aug 18, 2023
Tampa
Innovation Academy 2023
AAD 2023 Innovation Academy in pictures
Aug 18, 2023
Jennifer Hsiao, MD, FAAD
Innovation Academy 2023
Hidradenitis suppurativa: Clinical pearls from your peers
Aug 12, 2023
Left to right: Charlene Lam, MD, MPH, FAAD, and Alexandra Flamm, MD, FAAD
Innovation Academy 2023
Learn to lead — and adapt
Aug 12, 2023
Barbara Ann Gilchrest, MD, FAAD
Innovation Academy 2023
Better sunscreen education applies to all
Aug 12, 2023
Ginette Okoye, MD, FAAD
Innovation Academy 2023
Stepping up for the underserved
Aug 12, 2023
AAD
Facebook iconInstagram iconTwitter X icon
© Ascend Media All rights reserved. DermWorld Meeting News Central is a publication of the American Academy of Dermatology.